Richard F. Riedel

Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial

Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack et al. · The Lancet Oncology · 2017 · 1.4K citations · Full text

Oncology, Pathology, Advanced Soft-tissue Sarcoma +5

NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

George D. Demetri, Margaret von Mehren, Cristina R. Antonescu et al. · Journal of the National Comprehensive Cancer Network · 2010 · 1.2K citations

Surgical Oncology, Immunology, Gastroenterology +18

Soft Tissue Sarcoma, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, John M. Kane, Mark Agulnik et al. · Journal of the National Comprehensive Cancer Network · 2022 · 1.1K citations · Full text

Surgical Oncology, Tumoral Pathology, Soft Tissue Sarcoma +15

Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

Margaret von Mehren, R. Lor Randall, Robert S. Benjamin et al. · Journal of the National Comprehensive Cancer Network · 2018 · 720 citations · Full text

Surgical Oncology, Cancer Management, Pathology +16

Genomic signatures to guide the use of chemotherapeutics

Anil Potti, Holly K. Dressman, Andrea Bild et al. · Nature Medicine · 2006 · 593 citations

Genomic Signatures, Biomolecular Tool, Tumor Heterogeneity +6